ArticleAdvances in therapy2023

One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib.

Martin Bergman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.